Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-22-014507

President and CEO acquired 23,724 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tesi Raymond Joseph · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-22 Grant or award : show line 1 in the form +23,724 $8.43 $199,993 1,514,398 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-21 Grant or award : show line 2 in the form Option (right to buy) +130,000 130,000 D
Loading xslF345X03/ownership.xml…